Paris - Delayed Quote EUR
PHAXIAM Therapeutics S.A. (PHXM.PA)
As of 3:04 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
--
-31,764.0000
-56,770.0000
-51,720.0000
-43,310.0000
Investing Cash Flow
--
38,127.0000
-345.0000
-1,475.0000
-19,838.0000
Financing Cash Flow
--
-1,768.0000
44,712.0000
25,449.0000
40.0000
End Cash Position
--
38,789.0000
33,699.0000
44,446.0000
73,173.0000
Interest Paid Supplemental Data
--
223.0000
374.0000
326.0000
195.0000
Capital Expenditure
--
-85.0000
-298.0000
-1,141.0000
-20,133.0000
Issuance of Capital Stock
--
--
34,631.0000
118.0000
--
Issuance of Debt
--
3,081.0000
12,157.0000
27,134.0000
--
Repayment of Debt
--
-4,626.0000
-1,702.0000
-1,677.0000
-1,716.0000
Free Cash Flow
--
-31,849.0000
-57,068.0000
-52,861.0000
-63,443.0000
12/31/2019 - 5/7/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALMDP.PA Medesis Pharma S.A.
0.4120
+0.24%
IPH.PA Innate Pharma S.A.
1.6220
0.00%
DBV.PA DBV Technologies S.A.
0.7150
-0.70%
NANO.PA Nanobiotix S.A.
3.9560
+0.66%
GNFT.PA Genfit S.A.
4.8550
-9.93%
ALTHX.PA Theranexus Société Anonyme
0.5000
-1.19%
6IV.BE Inventiva SA
2.4100
-0.62%
0K4.F Akero Therapeutics, Inc.
32.18
-1.83%
IDD.F Innate Pharma S.A.
1.5980
-1.24%
ALQGC.PA Quantum Genomics Société Anonyme
0.0721
0.00%